SoftBank vs Pfizer
Comparação do valor de mercado ao longo do tempo
SoftBank
$163.3B
Posição #102
Pfizer
$171.2B
Posição #97
Valor de mercado ao longo do tempo
Momentos-chave
- SoftBank ultrapassou Pfizer até 2025
- Pfizer ultrapassou SoftBank até 2026
Comparação ano a ano
| Ano | SoftBank | Pfizer | LÃder |
|---|---|---|---|
| 2026 | $163.3B | $171.2B | Pfizer |
| 2025 | $167.8B | $137.3B | SoftBank |
| 2024 | $87.2B | $136.4B | Pfizer |
| 2023 | $59.5B | $139.5B | Pfizer |
| 2022 | $52.9B | $237.5B | Pfizer |
| 2021 | $50.5B | $265.1B | Pfizer |
| 2020 | $74.5B | $159.1B | Pfizer |
| 2019 | $43.6B | $154.3B | Pfizer |
| 2018 | $33.2B | $165.8B | Pfizer |
| 2017 | $40.4B | $132.8B | Pfizer |
| 2016 | $35.0B | $114.6B | Pfizer |
| 2015 | $27.4B | $109.7B | Pfizer |
| 2014 | $32.0B | $102.5B | Pfizer |
| 2013 | $40.7B | $97.3B | Pfizer |
| 2012 | $13.8B | $77.1B | Pfizer |
| 2011 | $9.7B | $64.0B | Pfizer |
| 2010 | $12.0B | $49.7B | Pfizer |
| 2009 | $9.3B | $49.6B | Pfizer |
| 2008 | $6.8B | $45.8B | Pfizer |
| 2007 | $9.8B | $55.2B | Pfizer |
| 2006 | $9.8B | $60.1B | Pfizer |
| 2005 | $21.2B | $52.1B | Pfizer |
| 2004 | $7.1B | $58.3B | Pfizer |
| 2003 | $4.6B | $75.0B | Pfizer |
| 2002 | $1.9B | $63.7B | Pfizer |
| 2001 | $3.0B | $81.9B | Pfizer |
| 2000 | $5.6B | $93.5B | Pfizer |